Pharma Pulse: Cholesterol Imbalance Tied to Depression Risk, Lilly Acquires Aderum Biotechnologies, and Cambrex Expands API Manufacturing | Pharmaceutical Commerce

Pharma Pulse: Cholesterol Imbalance Tied to Depression Risk, Lilly Acquires Aderum Biotechnologies, and Cambrex Expands API Manufacturing | Pharmaceutical Commerce

2025-10-27 — Pharmaceutical Commerce

Pharma Pulse: Latest Developments Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & t…


How artist-designed shade structures are protecting vulnerable residents in US’s hottest city

How artist-designed shade structures are protecting vulnerable residents in US’s hottest city

2025-10-27 — The Art Newspaper

Artist-Designed Shade Structures in Phoenix, Arizona The city of Phoenix, Arizona, the hottest city in the US, is combating rising tempera…

Disruptive Innovation in MedTech: Rethinking the Future of Healthcare - TCT 2025 Update

Disruptive Innovation in MedTech: Rethinking the Future of Healthcare - TCT 2025 Update

2025-10-27 — Medical Dialogues

Disruptive Innovation in MedTech: Rethinking the Future of Healthcare - TCT 2025 Update The Medical Dialogues Bureau covers the news from …

Microsoft facing huge lawsuit involving millions of citizens over unfair software pricing - here's what we know

Microsoft facing huge lawsuit involving millions of citizens over unfair software pricing - here's what we know

2025-10-27 — TechRadar

Microsoft Facing Lawsuit Over Unfair Software Pricing Microsoft is being sued by the Australian Competition & Consumer Commission (ACCC) f…

Agencies and buyers need guard rails to protect CTV ad buying

Agencies and buyers need guard rails to protect CTV ad buying

2025-10-27 — The Media Online

CTV Ad Buying: A Murky World Agencies and buyers need protection when it comes to connected TV (CTV) ad buying, as the industry is filled …

© 2025 narangian.org News Aggregator
About Us · Privacy Policy · Terms of Service · DMCA Notice